Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Quick Stats
Jan 30, 202646.5
AI Score
HOLD2.58
Volume Ratio
Mar 10, 2026
Next Earnings
9
+ve Days (30d)
21
-ve Days (30d)
XGN Stock Summary
Last updated Jan 30, 2026
XGN is currently trading at $3.68, positioned below its 200-day moving average of $7.93, suggesting bearish momentum. The stock has a 52-week range of $2.6701 to $12.23.
Technical Analysis: The 50-day moving average stands at $6.25, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 16.079, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.241, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates XGN at 46.5/100 with a HOLD recommendation.
XGN (Exagen Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 16.079 |
| CMF (20) | -0.241 |
| ROC (10) | -23.81 |
| ADX (14) | 37.617 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.748 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -94.976 |
| MFI (14) | 13.473 |
XGN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
XGN Price vs Max Options Open Interest
XGN Max Change In Options Open Interest
XGN Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XGN Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XGN Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XGN Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Exagen Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
XGN Moving Averages Analysis
XGN (Exagen Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 4.4 |
| 20 | 5.08 |
| 30 | 5.47 |
| 50 | 6.25 |
| 100 | 8.44 |
| 200 | 7.93 |
XGN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 92.0 million |
| Earnings/Share ($) | -0.93 |
| Net Proft Margin (%) | -0.2994 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.858 |
| EPS Estimate Next Year ($) | -0.396 |
| WallStreet Target Price ($) | 14.7143 |
| Most Recent Quarter |